News Archive

2017

March

Media Release / Mar 21, 2017

Novartis’ secukinumab is first and only IL-17A inhibitor to potentially modify the course of psoriasis

Read More
Media Release / Mar 20, 2017

Novartis partners with ADB, Swiss Embassy to hold forum on achieving universal health coverage in developing countries

Read More
Media Release / Mar 12, 2017

Novartis global survey shows 85% fear blindness, but only 33% have regular eye examination

Read More
Media Release / Mar 12, 2017

Novartis partners with Philippine Glaucoma Society to help prevent blindness, promote regular eye exams

Read More

February

Media Release / Feb 28, 2017

Novartis, Philippine Dermatological Society form partnership to provide continuing medical education on psoriasis diagnosis and management

Read More
2016

December

Media Release / Dec 09, 2016

Novartis’ ranibizumab receives EU approval in new indication – Ranibizumab the only treatment available for a wide range of CNV conditions

Read More

November

Media Release / Nov 24, 2016

Novartis commends publication of major report which recommends broad use of dual bronchodilators to treat COPD

Read More

May

Media Release / May 16, 2016

Novartis renews partnership with St. Luke’s Medical Center as center of excellence in clinical trials

Read More

February

Media Release / Feb 01, 2016

Novartis Foundation commemorates World Leprosy Day with its continued efforts to go the last mile toward elimination

Read More

Pages